Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Lymphoproliferation Impairment and Oxidative Stress in Blood Cells from Early Parkinson's Disease Patients.

Vida C, Kobayashi H, Garrido A, Martínez de Toda I, Carro E, Molina JA, De la Fuente M.

Int J Mol Sci. 2019 Feb 12;20(3). pii: E771. doi: 10.3390/ijms20030771.

2.

Neurological Disorders in Central Spain, Second Survey: Feasibility Pilot Observational Study.

Hernández-Gallego J, Llamas-Velasco S, Bermejo-Pareja F, Vega S, Tapias-Merino E, Rodríguez-Sánchez E, Boycheva E, Serrano JI, Gil-García JF, Trincado R, Sánchez-Rodrigo JV, Cacho J, Contador I, Garcia-Ptacek S, Sierra-Hidalgo F, Cubo E, Carro E, Villarejo-Galende A, García García-Patino R, Benito-León J.

JMIR Res Protoc. 2019 Jan 10;8(1):e10941. doi: 10.2196/10941.

3.

The Melatonin Analog IQM316 May Induce Adult Hippocampal Neurogenesis and Preserve Recognition Memories in Mice.

Figueiro-Silva J, Antequera D, Pascual C, de la Fuente Revenga M, Volt H, Acuña-Castroviejo D, Rodríguez-Franco MI, Carro E.

Cell Transplant. 2018 Mar;27(3):423-437. doi: 10.1177/0963689717721217.

4.

Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.

Del Cerro P, Alquézar C, Bartolomé F, González-Naranjo P, Pérez C, Carro E, Páez JA, Campillo NE, Martín-Requero Á.

CNS Drugs. 2018 Jun;32(6):579-591. doi: 10.1007/s40263-018-0515-7.

PMID:
29736745
5.

Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer's Disease.

González-Sánchez M, Díaz T, Pascual C, Antequera D, Herrero-San Martín A, Llamas-Velasco S, Villarejo-Galende A, Bartolome F, Carro E.

Mol Neurobiol. 2018 Dec;55(12):8815-8825. doi: 10.1007/s12035-018-1039-3. Epub 2018 Mar 30.

PMID:
29603091
6.

Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Ber IL, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2018 Mar 1;8(1):4064. doi: 10.1038/s41598-018-22152-9.

7.

Amyloid β-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition.

Bartolome F, de la Cueva M, Pascual C, Antequera D, Fernandez T, Gil C, Martinez A, Carro E.

Alzheimers Res Ther. 2018 Feb 20;10(1):24. doi: 10.1186/s13195-018-0352-4.

8.

Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.

Ettcheto M, Sánchez-López E, Gómez-Mínguez Y, Cabrera H, Busquets O, Beas-Zarate C, García ML, Carro E, Casadesus G, Auladell C, Vázquez Carrera M, Folch J, Camins A.

Mol Neurobiol. 2018 Sep;55(9):7327-7339. doi: 10.1007/s12035-018-0868-4. Epub 2018 Feb 5.

PMID:
29404958
9.

Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer's Disease Patients. Relevant Role of Neutrophils in Oxidative Stress.

Vida C, Martinez de Toda I, Garrido A, Carro E, Molina JA, De la Fuente M.

Front Immunol. 2018 Jan 11;8:1974. doi: 10.3389/fimmu.2017.01974. eCollection 2017.

10.

The choroid plexus harbors a circadian oscillator modulated by estrogens.

Quintela T, Albuquerque T, Lundkvist G, Carmine Belin A, Talhada D, Gonçalves I, Carro E, Santos CRA.

Chronobiol Int. 2018 Feb;35(2):270-279. doi: 10.1080/07420528.2017.1400978. Epub 2017 Nov 27.

PMID:
29172740
11.

Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.

Hernando S, Herran E, Figueiro-Silva J, Pedraz JL, Igartua M, Carro E, Hernandez RM.

Mol Neurobiol. 2018 Jan;55(1):145-155. doi: 10.1007/s12035-017-0728-7.

PMID:
28866799
12.

Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease.

Ettcheto M, Abad S, Petrov D, Pedrós I, Busquets O, Sánchez-López E, Casadesús G, Beas-Zarate C, Carro E, Auladell C, Olloquequi J, Pallàs M, Folch J, Camins A.

Mol Neurobiol. 2018 Jun;55(6):4885-4895. doi: 10.1007/s12035-017-0690-4. Epub 2017 Jul 27.

PMID:
28752224
13.

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin.

Carro E, Bartolomé F, Bermejo-Pareja F, Villarejo-Galende A, Molina JA, Ortiz P, Calero M, Rabano A, Cantero JL, Orive G.

Alzheimers Dement (Amst). 2017 May 26;8:131-138. doi: 10.1016/j.dadm.2017.04.002. eCollection 2017.

14.

Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Le Ber I, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2017 May 10;7(1):1666. doi: 10.1038/s41598-017-01678-4. Erratum in: Sci Rep. 2018 Mar 1;8(1):4064.

15.

Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons.

Ludtmann MHR, Arber C, Bartolome F, de Vicente M, Preza E, Carro E, Houlden H, Gandhi S, Wray S, Abramov AY.

J Biol Chem. 2017 May 26;292(21):8907-8917. doi: 10.1074/jbc.M116.762898. Epub 2017 Mar 30.

16.

Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin.

Bartolome F, Antequera D, Tavares E, Pascual C, Maldonado R, Camins A, Carro E.

J Neuroinflammation. 2017 Jan 31;14(1):26. doi: 10.1186/s12974-017-0800-2.

17.

Potential Role of Aminoprocalcitonin in the Pathogenesis of Alzheimer Disease.

Tavares E, Antequera D, López-González I, Ferrer I, Miñano FJ, Carro E.

Am J Pathol. 2016 Oct;186(10):2723-35. doi: 10.1016/j.ajpath.2016.06.006. Epub 2016 Aug 4.

PMID:
27497681
18.

Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and Disease.

Ferrer I, Garcia-Esparcia P, Carmona M, Carro E, Aronica E, Kovacs GG, Grison A, Gustincich S.

Front Aging Neurosci. 2016 Jul 5;8:163. doi: 10.3389/fnagi.2016.00163. eCollection 2016. Review.

19.

MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.

Pastor P, Moreno F, Clarimón J, Ruiz A, Combarros O, Calero M, López de Munain A, Bullido MJ, de Pancorbo MM, Carro E, Antonell A, Coto E, Ortega-Cubero S, Hernandez I, Tárraga L, Boada M, Lleó A, Dols-Icardo O, Kulisevsky J, Vázquez-Higuera JL, Infante J, Rábano A, Fernández-Blázquez MÁ, Valentí M, Indakoetxea B, Barandiarán M, Gorostidi A, Frank-García A, Sastre I, Lorenzo E, Pastor MA, Elcoroaristizabal X, Lennarz M, Maier W, Rámirez A, Serrano-Ríos M, Lee SE, Sánchez-Juan P; Dementia Genetic Spanish Consortium (DEGESCO).

J Alzheimers Dis. 2016;49(2):343-52. doi: 10.3233/JAD-150555.

20.

Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration.

Gartziandia O, Herran E, Pedraz JL, Carro E, Igartua M, Hernandez RM.

Colloids Surf B Biointerfaces. 2015 Oct 1;134:304-13. doi: 10.1016/j.colsurfb.2015.06.054. Epub 2015 Jul 3.

PMID:
26209963

Supplemental Content

Loading ...
Support Center